(Q35163373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Oligonucleotide delivery: a patent review (2010 - 2013) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ana Aviñó

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ramon Eritja

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

2

Anna Aviñó

1 reference

6 August 2017

language of work or name

English

0 references

publication date

5 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Patents

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

801-819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

Building oligonucleotide therapeutics using non-natural chemistries

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Viral vector-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Nonviral approach for targeted nucleic acid delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

The headgroup evolution of cationic lipids for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Trends in polymeric delivery of nucleic acids to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Nucleic acid carriers based on precise polymer conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

DNA-templated covalent coupling of G4 PAMAM dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Exploring chemical space with aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Cationic liposome-mediated gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

Polymer therapeutics-prospects for 21st century: the end of the beginning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.915944

10.1517/13543776.2014.915944

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json

release_tve3ktnna5hsdevo4fenhfjntu

17 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tve3ktnna5hsdevo4fenhfjntu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798406%20AND%20SRC:MED&resulttype=core&format=json